Malignant Peritoneal Neoplasm

Back to Diseases List

Associated Genetic Biomarkers

Overview

NCI Definition: A primary or metastatic malignant neoplasm involving the peritoneum. Representative examples include carcinoma and malignant mesothelioma. [1]

Biomarker-Directed Therapies

View Therapies for Malignant Peritoneal Neoplasm

Of the biomarker-directed therapies for malignant peritoneal neoplasm, 0 are FDA-approved in at least one setting and 0 have NCCN guidelines in at least one setting [3].

Olaparib +

Clinical Trials

View Clinical Trials for Malignant Peritoneal Neoplasm

Significant Genes in Malignant Peritoneal Neoplasm

BRCA1 +

BRCA2 +

Disease Details

Parent(s)

Peritoneal Neoplasm

Children

Malignant Peritoneal Solitary Fibrous Tumor, Peritoneal Carcinomatosis, Primary Peritoneal Carcinoma, Malignant Peritoneal Germ Cell Tumor, Peritoneal Malignant Mesothelioma, and Primary Peritoneal Carcinosarcoma

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.

Diseases /